The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCAT 2024 | The safety of splenectomy in pediatric patients with SCD
In this video, Maddalena Casale, MD, University of Campania Studies “Luigi Vanvitelli,” Naples, Italy, briefly comments on the age at which it is safe to perform splenectomy in pediatric patients with sickle cell disease (SCD), highlighting that the risk of splenic complications should not cause the procedure to be delayed in this patient population. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
